Saphetor
Switzerland - LausanneBiotechnology
Focus: Saphetor is a Swiss biotechnology company specializing in next-generation sequencing (NGS) analysis and interpretation through large-scale data integration. The company operates as a pre-revenue or early-stage biotech focused on computational genomics infrastructure.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Open Jobs
16+2 this month
Stable — net +2 jobs in 30d
7 added, 5 removed. Backfill posture.
Should You Work at Saphetor?
AI assessmentSuitable for early-career technologists and R&D professionals seeking deep NGS/data science experience, but limited financial visibility warrants careful due diligence on runway and exit strategy.
Why Work Here
- Ground-floor opportunity at a technology-focused biotech during active growth phase with 19 open roles across R&D, QA, and Data Science
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Saphetor
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.